- Investing.com
तुलना करने के लिए मीट्रिक्स | LON | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधLONपीअर्सक्षेत्र | |
|---|---|---|---|---|
पी/ई अनुपात | 0.0x | 31.8x | 0.0x | |
PEG अनुपात | 0.00 | 1.09 | 0.00 | |
क़ीमत/बुक | 0.0x | 3.2x | 0.0x | |
क़ीमत / एलटीएम बिक्री | 0.0x | 4.3x | 0.0x | |
अपसाइड (विश्लेषक लक्ष्य) | 0.0% | 25.4% | 0.0% | |
उचित मूल्य अपसाइड | अनलॉक करें | 4.4% | 0.0% | अनलॉक करें |
Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.